Debiopharm Group™ grants each year the Debiopharm Group Life Sciences Award(s) organised in collaboration with the EPFL (Ecole polytechnique fédérale de Lausanne, Switzerland) to encourage excellence amongst researchers in life sciences. The awards has a total value of CHF 100'000 and is currently comprised of one main Award and two junior Awards.
The main Award honours a European investigator below the age of 45 who has
made outstanding contributions in the area of basic or translational
oncology. It consists of a total of 50‘000 CHF, of which one fifth is a personal award,
while the rest will contribute to support the awardee’s research at his/her
home institution. A Jury of internationally renowned scientific experts evaluates the applications.
The two Junior Awards honour young researchers (postdocs or group leaders) under the age of 33 working at a Swiss institution in the wider area of cellular and molecular biology. The two junior awards consist of a total amont of CHF 25’000 each, of which one fifth is a personal award, while the rest will contribute to support the awardee’s research. A Jury of internationally renowned scientific experts evaluates the applications and invite preselected candidates to EPFL for a short presentation.
The Debiopharm Group Life Sciences Awards are a tribute of Debiopharm Group™ to innovation as the key engine to medical progress, and aim at motivating young innovative European researchers in the field of life sciences. The research performed by the candidates must show therapeutic and industrial potential in life sciences; novelty and originality; as well as importance and significance in connection with targeted therapeutic fields.
The 2011 Debiopharm Group Life Sciences Awards was granted on September 9th in Lausanne, Switzerland, on the occasion of the ISREC Life Sciences Symposium "Hallmarks & Horizons of Cancer" (for more information please visit http://isrec2011.epfl.ch).
Debiopharm Group™ thanks the EPFL School of Life Sciences for its continuous support in the organisation of this Award.
Awardees:
2011
Debiopharm Group™ Life Sciences Award awarded to:
- Professor Stefano Piccolo from the University of Padua, Italy
Junior Debiopharm Group™ Awards awarded to:
- Professor Etienne Meylan from the EPFL and
- Doctor Volker Busskamp from the Basel-based Friedrich Miescher Institute for Biomedical Research (FMI)
2010
- Prof. Jean-Christophe Leroux, Drug Formulation & Delivery, Institute of Pharmaceutical Sciences, ETH Zürich, Switzerland
Professor Leroux from ETH receives the Debiopharm Life Sciences Award 2010
2009
- Dr Lluis Quintana-Murci, UP Human Evolutionary Genetics, Institut Pasteur, France
- Dr Manel Esteller, Epigenetics Laboratory at the National Cancer Center (CNIO) Madrid, Spain Debiopharm Life Sciences Award in Epigenetic Oncology goes to Dr Manel Esteller
2007
- Dr Zoltan Nusser, Hungarian Academy of Sciences, Budapest, Hungary
Debiopharm Life Sciences Award in Neurosciences Goes to Nusser
2006
- Dr Eduard Batlle, Institut de Recerca Biomèdica of Barcelona, Spain.
Debiopharm and EPFL honour Dr Eduard Batlle with the "Debiopharm Life Sciences Award"
